Laurus Labs Limited Total Liabilities
Laurus Labs Limited total liabilities. Based on the latest financial reports, Laurus Labs Limited (LAURUSLABS) has total liabilities worth Rs-54.31 Billion INR (≈ $-587.38 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check LAURUSLABS asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Laurus Labs Limited (2013–2026)
Total liabilities of Laurus Labs Limited from 2013 to 2026. This chart illustrates how Laurus Labs Limited's total liabilities have evolved over time, based on quarterly financial data. Explore LAURUSLABS strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Laurus Labs Limited Competitors by Total Liabilities
The table below lists competitors of Laurus Labs Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
RPM International Inc
NYSE:RPM
|
USA | $5.03 Billion |
|
iA Financial Corporation Inc
TO:IAG
|
Canada | CA$126.21 Billion |
|
GD Power Development Co Ltd
SHG:600795
|
China | CN¥381.37 Billion |
|
Lamar Advertising Company
NASDAQ:LAMR
|
USA | $5.93 Billion |
|
SOUTH32 Ltd
AU:S32
|
Australia | AU$4.54 Billion |
|
Rede D'Or São Luiz S.A.
SA:RDOR3
|
Brazil | R$81.23 Billion |
|
SK Telecom Co Ltd ADR
NYSE:SKM
|
USA | $16.82 Trillion |
|
Bank of Baroda
NSE:BANKBARODA
|
India | Rs18.06 Trillion |
Liability Composition Analysis (2013–2026)
This chart breaks down Laurus Labs Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see how large is Laurus Labs Limited's balance sheet.
Liquidity & Leverage Metrics
Laurus Labs Limited Total Liabilities Ratios Explained
Laurus Labs Limited total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | N/A | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.00 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | N/A | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Laurus Labs Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Laurus Labs Limited (2013–2026)
The table below shows the annual total liabilities of Laurus Labs Limited from 2013 to 2026.
| Year | Total Liabilities | Change |
|---|---|---|
| 2026-03-31 | Rs50.80 Billion ≈ $549.36 Million |
+7.33% |
| 2025-03-31 | Rs47.33 Billion ≈ $511.86 Million |
+10.81% |
| 2024-03-31 | Rs42.71 Billion ≈ $461.94 Million |
+18.27% |
| 2023-03-31 | Rs36.12 Billion ≈ $390.60 Million |
+0.08% |
| 2022-03-31 | Rs36.09 Billion ≈ $390.30 Million |
+14.57% |
| 2021-03-31 | Rs31.50 Billion ≈ $340.66 Million |
+59.05% |
| 2020-03-31 | Rs19.81 Billion ≈ $214.19 Million |
+11.72% |
| 2019-03-31 | Rs17.73 Billion ≈ $191.72 Million |
+15.56% |
| 2018-03-31 | Rs15.34 Billion ≈ $165.91 Million |
+15.96% |
| 2017-03-31 | Rs13.23 Billion ≈ $143.07 Million |
-8.84% |
| 2016-03-31 | Rs14.51 Billion ≈ $156.94 Million |
+29.36% |
| 2015-03-31 | Rs11.22 Billion ≈ $121.32 Million |
+22.63% |
| 2014-03-31 | Rs9.15 Billion ≈ $98.93 Million |
+105.95% |
| 2013-03-31 | Rs4.44 Billion ≈ $48.04 Million |
-- |
About Laurus Labs Limited
Laurus Labs Limited, together with its subsidiaries, manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally. The company offers Generics APIs and solid oral drug products for intermediates for anti-retroviral (ARV), anti-diabetic, cardiovascular, anti-asthma, ophthalmology, oncology, and gastroenterology. It also develops and manufactures animal… Read more